These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 94272)

  • 1. [Effect of embryonal organ-specific RNA on myocardial hypertrophy].
    Skuba ND; Levkova NA
    Biull Eksp Biol Med; 1979 Nov; 88(11):621-3. PubMed ID: 94272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of myocardial hypertrophy on heart dynamics and contractility].
    Krayenbühl HP
    Verh Dtsch Ges Kreislaufforsch; 1972; 38():65-76. PubMed ID: 4268348
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pre- and postoperative study of myocardial hypertrophy and left ventricular function in adult aortic valve stenosis].
    Fechner J; Drobinski G; Eugène M; Kin G; Evans J; Bejean-Lebuisson A; Grosgogeat Y
    Ann Med Interne (Paris); 1982; 133(8):538-43. PubMed ID: 6221682
    [No Abstract]   [Full Text] [Related]  

  • 4. [Exercise electrocardiography in left ventricular hypertrophy].
    Willems G; Klepzig H; Willems D
    Med Klin; 1971 Aug; 66(35):1142-7. PubMed ID: 4255119
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of L-arginine on the development of experimental cardiac hyperfunction and hypertrophy].
    Lahodych TS; Karvats'kyĭ IM; Shevchuk VH
    Fiziol Zh (1994); 2001; 47(2):46-51. PubMed ID: 11392114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of verapamil on diastolic left ventricular function in myocardial hypertrophy of different origin.
    Hess OM; Murakami T; Krayenbühl HP
    Z Kardiol; 1987; 76 Suppl 3():82-6. PubMed ID: 2963452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative identification of patients likely to have left ventricular dysfunction after aortic valve replacement. Participants in the Veterans Administration Cooperative Study on Valvular Heart Disease.
    Hwang MH; Hammermeister KE; Oprian C; Henderson W; Bousvaros G; Wong M; Miller DC; Folland E; Sethi G
    Circulation; 1989 Sep; 80(3 Pt 1):I65-76. PubMed ID: 2670330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular function and myocardial structure in aortic valve disease before and after surgery.
    Krayenbuehl HP; Hess OM; Schneider J; Turina M
    Herz; 1984 Oct; 9(5):270-8. PubMed ID: 6500480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Absence, in the hypertrophied rat heart caused by aortocaval fistula, of several metabolic and electrophysiological changes seen in other models of hypertrophy].
    Thollon C; Aussedat J; Verdetti J; Kreher P
    C R Acad Sci III; 1985; 300(16):607-12. PubMed ID: 3158383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of alpha-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats.
    Stilli D; Bocchi L; Berni R; Zaniboni M; Cacciani F; Chaponnier C; Musso E; Gabbiani G; Clément S
    Exp Physiol; 2006 May; 91(3):571-80. PubMed ID: 16452123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of tachycardia on hemodynamics and coronary circulation. Different relevance of ventricular tachycardias for healthy persons, coronary patients and patients with left heart hypertrophy].
    Thormann J
    Fortschr Med; 1984 Oct; 102(40):1022-8. PubMed ID: 6238884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy.
    Yang XP; Samaja M; English E; Benatti P; Tarantola M; Cardace G; Motterlini R; Micheletti R; Bianchi G
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):88-98. PubMed ID: 1383636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of left ventricular performance in aortic stenosis, aortic regurgitation and mitral regurgitation from the stroke work/left ventricular mass ratio.
    Nitenberg A; Richalet JP; Laurent D
    Eur J Cardiol; 1979 Oct; 10(4):279-94. PubMed ID: 159181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Function and reserve of the hypertrophic left ventricle in aortic valve defects].
    Schwarz F; Thormann J; Ensslen R; Feige A
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():171-4. PubMed ID: 137610
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiotensin-converting-enzyme inhibitor and heart hypertrophy].
    Riegger AJ; Kromer EP
    Wien Med Wochenschr; 1990 Jan; 140(1-2):46-9. PubMed ID: 2137956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats.
    Balakumar P; Singh M
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):418-24. PubMed ID: 17169122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, pattern, and functional impact of late gadolinium enhancement in left ventricular hypertrophy due to aortic valve stenosis.
    Nassenstein K; Bruder O; Breuckmann F; Erbel R; Barkhausen J; Schlosser T
    Rofo; 2009 May; 181(5):472-6. PubMed ID: 19241322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chamber and myocardial compliance in pressure overload hypertrophy.
    Peterson KL; Ricci D; Tsuji J; Sasayama S; Ross J
    Eur J Cardiol; 1978 Jun; 7 Suppl():195-211. PubMed ID: 149665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of tashinone on nitric oxide synthase in hypertrophic cardiomyocyte of rats suffered abdominal aorta constriction].
    Li YS; Wang ZH; Yan L; Yong YQ; Wang J; Liang QS; Zheng Z; Yang GT
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1446-50. PubMed ID: 18837353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.